Few conditions have such a memorable nickname. Dupuytren's disease, in which connective tissue in the palm changes and fingers can curl inward, is widely known as the “Viking disease”. The story sounds neat: Norse seafarers carry an ailment across Europe. Yet the only genetic test of that exact idea I know of found no Viking excess, and the much-quoted Neanderthal study points to a far older past. This article is a fact check on the history of a name, not medical guidance.
Dupuytren's disease affects the palmar fascia, the tough sheet of connective tissue beneath the skin of the palm. Palpable cords can form there and draw fingers into a bent position. In 2019 Ng, Lawson, Winney and Furniss called it the most common inherited disease of connective tissue and, at the same time, a typical “complex” disease: many inherited factors act together rather than a single gene.
That is all the medicine you will find here. The article assesses neither treatments nor anyone's personal risk. If you notice changes in your hand, the right place to discuss them is a doctor's office.
I could not establish who used the phrase first. Alan Thurston, in his 2003 review, writes that as recently as 1962 an origin in the “Nordic races” was proposed, and that the condition thus became known as the Viking disease. For this he points to Early (1962) and to John Hueston's book (1963), neither of which I could read. Charles Eaton, by contrast, wrote on dupuytrens.org in 2019 that “Dupuytren” and “Viking” were first joined in print in 1985, in Hueston's second textbook. So the accounts differ. The wording shows the age of the idea: it argues from peoples and “races”, not from measured genetic variants. Ng and colleagues cite a 2001 paper by Adrian Flatt for the formula “disease of the Vikings”; its abstract itself speaks only of “tradition”. That documents the use of the term rather than its invention.
Ng and colleagues sum up the supporting case in two points. Prevalence seems highest in Iceland and the Scandinavian countries. And the disease is absent from ancient and medieval European writing, apart from a few Nordic miracle stories. Both are clues that fit the story, but neither proves an origin. Thurston's verdict is brisk: there is little evidence for a Nordic origin, and given how widespread the disease now is, tracing it to a single population would be nearly impossible.
The earliest supposed evidence comes from Old Norse literature. In 1993 Whaley and Elliot, under the title “Dupuytren's disease: a legacy of the north?”, gathered four miracle cures said to have been worked by priests in Orkney and Iceland in the 12th and 13th centuries; Thurston names the Icelandic sagas as their source. I could not read that paper itself, only its summary in Thurston and Ng, so I cannot say here which sagas are meant.
Even that summary suggests three caveats. Thurston explicitly writes of “putative” Dupuytren's: this is a diagnosis made from a miracle story, centuries later, with no hand to examine. Second, the accounts postdate the Viking Age, which is usually taken to end in the 11th century; they describe a Christian society with priests. Third, a report from the North says little about distribution when the North happens to have preserved so much narrative literature. For more on this tradition see the articles on the Icelandic sagas and the Earls of Orkney. The medicine of the period is covered in Viking medicine. I know of no archaeological proof, and connective tissue generally does not survive burial.
Thurston credits the first written description to the Basel physician Felix Platter in 1614, a Swiss source rather than a Norse one. The Englishman Henry Cline (1750–1827), a pupil of John Hunter according to Thurston, was by the same account the first to dissect an affected hand. In 1822 Astley Cooper described the palmar aponeurosis itself as a possible cause of the contracture.
Even so, the name belongs to the Paris surgeon Guillaume Dupuytren (1777–1835). On 5 December 1831, according to Larsen (1966), he showed his students the hands of a coachman; the printed account is dated to 1831 or 1832, depending on the source. Thurston credits him with advancing understanding considerably but also reports a misrepresentation: that Cooper had supposedly declared the condition incurable.
“Asthley [sic] Cooper … le célèbre chirurgien anglais lui répondit que la maladie était incurable.” – “The celebrated English surgeon replied to him that the disease was incurable.”Dupuytren, Leçons orales de clinique chirurgicale, French wording only as given in Thurston 2003 (his reference 9), original work not seen, so the referent of “lui” is open; my own translation. A 19th-century statement, not current medical knowledge.
What matters for the name is simple: no Viking appears in this history of research. According to Thurston, Goyrand described familial clustering in 1833, recognising heredity early. In the accounts I read, the Viking link appears only in the 20th century, as an explanation for an observed distribution.
A second story leads to the Hebrides. Thurston reports that in the Western Isles of Scotland the condition was known as the “Curse of the MacCrimmons”. The MacCrimmons were pipers to the MacLeod chiefs of Skye; bent fingers made playing impossible. Thurston places this in the 16th century but gives no reference, and the other versions I found are unsourced too. It is an appealing piece of tradition, not an established diagnosis. As evidence of a Scandinavian origin it proves nothing: at most it shows that one family in one region is said to have been affected. For the regional background see Vikings in Scotland.
Nobody disputes that the disease is often recorded in the North. Thurston gives 9.4 percent of men and 2.8 percent of women in a small Norwegian town, and 19.2 and 4.4 percent in the Reykjavik Study, whose sample covered only people aged 46 to 74 (Gudmundsson et al. 2000). Higher figures appear for older people, around 30 percent, though the group varies (over 65 in Norway in Thurston, men over 60 in northern Europe in Ågren and the accompanying press release); in the Reykjavik Study it was 39.5 percent among men aged 70 to 74. Such numbers depend heavily on who is counted, and how.
At the same time the disease occurs where no Viking incursions can be assumed. Ng and colleagues name Japan, Spain, Ethiopia and India. Spain is a poor example, since Viking raids on the Iberian Peninsula are recorded in the 9th century; Japan, Ethiopia and India carry the argument better. Thurston reports a frequency in Japan similar to northern Europe but with much milder disease, plus case reports from Thailand, Taiwan, India and Pakistan, and from Africa and among Black Americans. He also notes that prevalence in people with dark skin has not been conclusively shown, and that some authors questioned the ancestry of such patients: a sign of how far prior assumptions steered the gaze.
Large registries are clearer. In the Michigan cohort, Ågren and colleagues found 0.49 percent among people of primarily African ancestry and 1.37 percent among those of primarily European ancestry; in the Million Veteran Program they cite, the figures are 0.13 and 0.73 percent. So the difference is real, but the disease is nowhere “purely European”.
Caution is needed with the 2020 meta-analysis by Salari and colleagues, often used as a world map. It calculates 17.2 percent for Africa, 15.3 for Asia, 10.3 for Europe and 2.3 for the Americas. That does not mean Africa is hit hardest: the African value rests on just two studies with 1,111 people, variation between studies is extreme for the other continents and overall (I² above 99 percent, a measure of inconsistency), and the authors concede that not all samples were random. It gives no separate figure for northern Europe at all. Thurston notes from the other side that many large surveys are Scandinavian, which alone makes the North highly visible.
The question in the title can be tackled genetically, and Ng, Lawson, Winney and Furniss did just that in 2019 in “Is Dupuytren's disease really a ‘disease of the Vikings’?”. They used data from 7,912 patients and 12,937 controls, along with the People of the British Isles study of 2,039 people from the UK, compared with 6,209 people from across Europe. Britain works as a test bed because the Scandinavian share varies regionally and is especially large on Orkney.
The result: no analysis showed an excess of Norse ancestry in patients, and the genetic risk score showed no pattern even where Viking ancestry is high, such as Orkney. The authors conclude there is no genetic evidence for a Viking origin. The limits belong in the picture too. The test used present-day Britons and the risk variants known at the time (21 of 26 could be analysed). A British result does not prove that no variant ever crossed the North Sea, but it removes the theory's main prediction. I know of no study testing these variants in Viking-Age skeletons. That “Vikings” were never a single gene pool anyway is explained in Viking descendants and DNA.
The paper often cited as “the Neanderthal study” is the one Richard Ågren, Svante Pääbo, Hugo Zeberg and colleagues published in June 2023 in Molecular Biology and Evolution. I did not come across a newer Neanderthal study on this subject during research, though I cannot rule one out.
The team analysed three biobanks from the US, UK and Finland, totalling 7,871 cases and 645,880 controls, mainly of European ancestry. Of 61 genomic regions found, three carry segments of Neanderthal DNA, including the second and third strongest; the remaining one ranks only 52nd. The strongest region is therefore not among them, whatever some headlines imply. For the strongest Neanderthal variant they identify the gene EPDR1 as the likely cause.
How much is that? The three regions account for about 8.4 percent of the heritability explained by all 61 hits, clearly more than expected. The authors conclude that admixture with Neanderthals has shaped regional differences in prevalence. It is a building block, not the cause: most regions do not come from Neanderthals.
The 2023 headlines loved pairing the two, but tens of thousands of years separate them. According to the press release, Neanderthal DNA makes up about one to two percent of the genome of people with roots outside Africa, which covers people in Asia as much as in Scandinavia. Zeberg himself cautions there against exaggerating the connection between Neanderthals and Vikings. The paper's authors likewise mention the nickname only with the remark that the designation has been opposed. The study also mainly covers people of European ancestry and did not measure Viking ancestry at all.
Why is Dupuytren's called the “Viking disease”? Because it is often recorded in northern Europe and a Nordic origin was suggested in the 20th century. The name is an interpretation, not a finding. Who coined it could not be established.
Did Vikings have this disease? That cannot be clearly shown. Individuals may have been affected, but I know of no evidence from the Viking Age itself; the four miracle accounts are later and uncertain.
Does the disease come from Neanderthals? In part, Neanderthal variants influence risk in Europeans, including two particularly strong ones. The great majority of known risk regions do not come from them.
Does my ancestry say anything about my risk? This history article doesn't answer that. Questions about your own health belong with a doctor.
Viking medicine
Viking descendants and DNA
Viking women on the move: what DNA shows
Icelandic sagas
The Earls of Orkney
Vikings in Scotland
Viking medicine · Am I Descended from the Vikings? What DNA Tests Really Reveal · The great Viking DNA study · Typically Viking? · Vikings in Spain.
Read in full: none; all texts were read as excerpts through a retrieval tool.
Read only via summary/retrieval tool:
Second-hand only (as reported by Ng or Thurston, not read): Whaley DC, Elliot D: Dupuytren's disease: a legacy of the north? Journal of Hand Surgery (Br) 18-B, 1993, pp. 363–367; Early 1962; Hueston 1963 and 1985; Platter 1614; Cooper 1822; Dupuytren; Goyrand 1833.
To some an ancient Germanic sun-sanctuary, to others a Christian place of pilgrimage – the Externsteine in the …
Read more →When snow falls thickly, some people in Germany still say: "Frau Holle is shaking out her beds." It is a nursery …
Read more →Friday is named after Frigg, Odin's wife – known on the Continent as Frija and in Old English as Frīg – not after …
Read more →God of War (2018) and God of War Ragnarök (2022) have introduced Norse mythology to millions of players. But how much …
Read more →